Background Bacterial co-pathogens are commonly identified in viral respiratory infections
and are important causes of morbidity and mortality. The prevalence of bacterial infection in …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance. …

Background COVID-19 and antimicrobial resistance (AMR) are two intersecting global public
health crises. Objective We aimed to describe the impact of the COVID-19 pandemic on …

Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Background There is growing evidence supporting the efficacy of shorter courses of antibiotic
therapy for common infections. However, the risks of prolonged antibiotic duration are …

Importance Antibiotic overuse contributes to adverse drug effects, increased costs, and
antimicrobial resistance. Objective To evaluate peer-comparison audit and feedback to high-…

Background: Unnecessary antibiotic use in the community in Canada is not well defined.
Our objective was to quantify unnecessary antibiotic prescribing in a Canadian primary care …

Background The coronavirus disease 2019 (COVID-19) pandemic has potentially impacted
outpatient antibiotic prescribing. Investigating this impact may identify stewardship …

Background: Pharmacist prescribing authority is expanding, while antimicrobial resistance
is an increasing global concern. We sought to synthesize the evidence for antimicrobial …